Hap Trading, LLC Viking Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024
BUY
$17.4 - $94.5 $260,999 - $1.42 Million
15,000 New
15,000 $3.38 Million
Q3 2019

Nov 12, 2019
SELL
$6.55 - $8.6 $77,290 - $101,480
-11,800 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$7.67 - $10.63 $65,962 - $91,418
-8,600 Reduced 42.16%
11,800 $8,000
Q1 2019

May 10, 2019
BUY
$7.58 - $9.94 $154,632 - $202,776
20,400 New
20,400 $12,000

Others Institutions Holding VKTX

# of Institutions
478
Shares Held
66.1M
Call Options Held
6.24M
Put Options Held
3.01M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.28B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email